Zhao, Y., OuYang, G., Shi, J., Luo, Y., Tan, Y., Yu, J., . . . Huang, H. (2021). Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation. Front Pharmacol.
Style de citation ChicagoZhao, Yanmin, et al. "Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With CGVHD After Allogeneic Hematopoietic Stem Cell Transplantation." Front Pharmacol 2021.
Style de citation MLAZhao, Yanmin, et al. "Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With CGVHD After Allogeneic Hematopoietic Stem Cell Transplantation." Front Pharmacol 2021.